Standout Papers

National Institute on Aging–Alzheimer's Associati... 1999 2026 2008 2017 2.0k
  1. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (2012)
    Bradley T. Hyman, Creighton H. Phelps et al. Alzheimer s & Dementia
  2. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2011)
    Thomas J. Montine, Creighton H. Phelps et al. Acta Neuropathologica
  3. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease (1999)
    Lih-Fen Lue, Yu‐Min Kuo et al. American Journal Of Pathology
  4. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease (2013)
    Jeffrey H. Kordower, C. Warren Olanow et al. Brain
  5. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012)
    Thomas G. Beach, Sarah E. Monsell et al. Journal of Neuropathology & Experimental Neurology
  6. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020)
    Shorena Janelidze, Niklas Mattsson et al. Nature Medicine
  7. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders (2010)
    Thomas G. Beach, Charles H. Adler et al. Acta Neuropathologica
  8. Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (2008)
    Masato Hasegawa, Tetsuaki Arai et al. Annals of Neurology
  9. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup (2024)
    Clifford R. Jack, J. Scott Andrews et al. Alzheimer s & Dementia
  10. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (2012)
    Christopher M. Clark, Michael J. Pontecorvo et al. The Lancet Neurology
  11. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (2009)
    Thomas G. Beach, Charles H. Adler et al. Acta Neuropathologica
  12. Low clinical diagnostic accuracy of early vs advanced Parkinson disease (2014)
    Charles H. Adler, Thomas G. Beach et al. Neurology
  13. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis (2021)
    Aliza P. Wingo, Yue Liu et al. Nature Genetics
  14. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads (2023)
    Gemma Salvadó, Rik Ossenkoppele et al. EMBO Molecular Medicine

Immediate Impact

6 by Nobel laureates 39 from Science/Nature 184 standout
Sub-graph 1 of 17

Citing Papers

Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
2025 Standout
Single-cell multiregion dissection of Alzheimer’s disease
2024 StandoutNature

Works of Thomas G. Beach being referenced

Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis
2021 Standout
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
2012 Standout

Author Peers

Author Last Decade Papers Cites
Thomas G. Beach 15480 10338 8734 401 30.8k
Matthew P. Frosch 16468 8153 9195 294 31.5k
Thomas J. Montine 10578 6561 8468 431 26.3k
Charles Duyckaerts 9353 6446 6511 284 21.1k
Takeshi Iwatsubo 22599 12059 14628 454 40.6k
William R. Markesbery 21881 4988 16818 402 49.0k
Eva Braak 18139 10887 7497 151 34.6k
Allen D. Roses 17680 3713 14249 355 34.2k
Dietmar Rudolf Thal 11332 4846 5005 232 18.6k
Peter Davies 13807 4133 8306 231 22.6k
Kelly Del Tredici 11117 19953 6065 142 32.4k

All Works

Loading papers...

Rankless by CCL
2026